Valuation: Ventripoint Diagnostics Ltd.

Market Cap 15.43M 11.03M 9.88M 9.12M 8.25M 1.05B 15.68M 109M 43.4M 550M 41.41M 40.53M 1.74B P/E 2024
-3.22x
P/E 2025 -7.24x
Enterprise Value 17.99M 12.86M 11.52M 10.63M 9.62M 1.22B 18.28M 127M 50.59M 641M 48.27M 47.25M 2.03B EV / Sales 2024
187x
EV / Sales 2025 145x
Free-Float
98.4%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Ventripoint Diagnostics Ltd.

1 day-5.88%
1 week-11.11%
Current month-5.88%
1 month-5.88%
3 months-23.81%
6 months-36.00%
Current year-42.86%
1 week 0.08
Extreme 0.075
0.1
1 month 0.08
Extreme 0.075
0.1
Current year 0.08
Extreme 0.075
0.19
1 year 0.08
Extreme 0.075
0.19
3 years 0.08
Extreme 0.075
0.36
5 years 0.08
Extreme 0.075
0.51
10 years 0.06
Extreme 0.065
0.92
Manager TitleAgeSince
Chief Executive Officer - 2024-02-04
Director of Finance/CFO - 2025-12-02
Chief Executive Officer 74 2010-09-30
Director TitleAgeSince
Chairman 74 2019-12-16
Director/Board Member - 2021-10-24
Director/Board Member - 2021-12-19
Date Insider Type Main position Quantity % Market Cap. Importance
8/1/26 Other

Director

0 0%
8/1/26 Other

Director

0 0%
8/1/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-5.88%-11.11%-20.00%-48.39% 11.68M
+0.71%+4.82%+27.02%+64.39% 260B
+1.24%+3.15%+10.73%+26.13% 165B
+1.03%+1.11%-16.52%+73.28% 154B
+0.61%-7.22%-57.44%-13.79% 61.49B
+2.90%+4.83%+14.21%+53.04% 52.9B
+0.70%+2.83%-12.22%-6.48% 52.84B
-2.35%-3.79%+8.26%+63.75% 51.46B
-0.18%+4.18%+26.50%+76.27% 51.16B
+0.67%+5.37%+39.77%+96.14% 46.85B
Average -0.05%+0.65%+2.03%+38.43% 89.57B
Weighted average by Cap. +0.76%+1.41%+7.23%+50.97%

Financials

2024 2025
Net sales 95.17K 68.06K 60.96K 56.24K 50.9K 6.48M 96.71K 671K 268K 3.39M 255K 250K 10.74M 180K 129K 115K 106K 96.22K 12.25M 183K 1.27M 506K 6.41M 483K 473K 20.31M
Net income -4.92M -3.52M -3.15M -2.91M -2.63M -335M -5M -34.69M -13.84M -175M -13.2M -12.92M -555M -3.2M -2.29M -2.05M -1.89M -1.71M -218M -3.25M -22.56M -9M -114M -8.59M -8.41M -361M
Net Debt 1.57M 1.13M 1.01M 930K 842K 107M 1.6M 11.1M 4.43M 56.11M 4.23M 4.14M 178M 2.56M 1.83M 1.64M 1.51M 1.37M 174M 2.6M 18.02M 7.19M 91.11M 6.86M 6.71M 289M
Projected Income Statement - Annual - Ventripoint Diagnostics Ltd.
Logo Ventripoint Diagnostics Ltd.
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
Employees
-
Date Price Change Volume
26-10-29 $0.0800 -5.88% 1,772
26-10-28 $0.0850 +6.25% 202,075
26-10-27 $0.0800 -15.79% 436,020
26-10-26 $0.0950 +5.56% 23,002
26-10-23 $0.0900 0.00% 126,200